·¬ΗΡΚΣΖ΅

Meeting Coverage

ACAAI

American College of Allergy, Asthma & Immunology

Here's Why People Think They Developed Food Allergies

Survey finds that 13% thought genetics were responsible, 27% blamed eating behaviors

ACAAI over a photo of Anaheim Convention Center in Anaheim, California.

Latest ACAAI Meeting Coverage

Added Leukotriene Receptor Antagonists Show Benefits in Chronic Urticaria

Off-label use along with antihistamines improved activity, itch, and wheal count scores

November 15, 2023
Novel BTK Inhibitor for Chronic Hives Wins in Phase III Trials

Remibrutinib demonstrated superiority over placebo in both the REMIX-1 and -2 trials

November 14, 2023
Asthma-Tracking App Shows Some Promise for Reducing ED Visits

No benefit for the privately insured in trial, but participants on Medicaid had lower risk

November 14, 2023
AI Gets It Mostly Right on Allergy Myths

ChatGPT sometimes gave opposite answers, and clinicians themselves didn't always agree

November 13, 2023
Many Primary Care Docs Unfamiliar With Biologics for Asthma

In a survey, 42% of PCPs said they were "not familiar" with biologic therapies for asthma

November 13, 2023
Benefits of Peanut Allergy Skin Patch for Toddlers Grow After First Year

Open-label extension of EPITOPE trial shows increased tolerance at 24 months

November 13, 2023
Peanut Allergy Toothpaste Shows Promise in Phase I Trial

Patients taking the oral mucosal immunotherapy reported only minor adverse effects

November 13, 2023
New Treatment Options on the Horizon for Chronic Spontaneous Urticaria

Monoclonal antibodies, BTK inhibitor alleviate symptoms when antihistamines fall short

November 16, 2022
Skin Patch Helped Young Kids With Peanut Allergies

More kids had responses, decreased symptom severity, versus those who received placebo

November 15, 2022
Sublingual Film Delivers Epinephrine

Pharmacokinetics in healthy cohort looks promising

November 15, 2022
CRISPR Shows Promise for Hereditary Angioedema in First-in-Human Trial

No safety concerns reported and swelling attacks declined

November 15, 2022
Toddlers With Peanut Allergy Tolerate Oral Immunotherapy

PTAH, already approved for those ages 4-17, also attenuated the sensitivity in younger children

November 14, 2022
Asthma Deterioration Slowed With Combination Inhaler

Albuterol-budesonide also reduced time with severe exacerbations

November 14, 2022
Parents, Providers Still Not Following Guidelines for Early Peanut Introduction

Implementation barriers included parental fears, pediatrician time crunch

November 13, 2022